CRIS Current Research Information System

BARTOLETTI, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.798
AS - Asia 6.557
EU - Europa 5.144
Continente sconosciuto - Info sul continente non disponibili 487
SA - Sud America 435
AF - Africa 390
OC - Oceania 19
Totale 20.830
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.646
SG - Singapore 1.895
VN - Vietnam 1.814
CN - Cina 1.423
IT - Italia 1.175
GB - Regno Unito 1.127
SE - Svezia 713
DE - Germania 589
HK - Hong Kong 416
IN - India 300
FR - Francia 293
BR - Brasile 283
RU - Federazione Russa 233
IE - Irlanda 203
NL - Olanda 145
CI - Costa d'Avorio 137
KR - Corea 121
JP - Giappone 115
BG - Bulgaria 112
BD - Bangladesh 84
CH - Svizzera 78
FI - Finlandia 78
CA - Canada 76
ZA - Sudafrica 75
TG - Togo 73
UA - Ucraina 64
JO - Giordania 63
ES - Italia 57
ID - Indonesia 56
AR - Argentina 53
AT - Austria 53
EE - Estonia 47
BE - Belgio 45
PH - Filippine 33
NG - Nigeria 31
TH - Thailandia 28
IQ - Iraq 27
MX - Messico 26
PL - Polonia 24
TR - Turchia 24
CO - Colombia 22
EC - Ecuador 21
PK - Pakistan 21
TW - Taiwan 21
SC - Seychelles 20
CL - Cile 17
IR - Iran 17
UZ - Uzbekistan 17
AU - Australia 16
MY - Malesia 16
RO - Romania 16
SA - Arabia Saudita 15
LT - Lituania 14
HR - Croazia 11
PY - Paraguay 11
TN - Tunisia 11
GR - Grecia 10
RS - Serbia 10
AE - Emirati Arabi Uniti 9
KE - Kenya 9
CR - Costa Rica 8
JM - Giamaica 8
PE - Perù 8
VE - Venezuela 8
IL - Israele 7
EG - Egitto 6
HN - Honduras 6
KZ - Kazakistan 6
PA - Panama 6
PT - Portogallo 6
SK - Slovacchia (Repubblica Slovacca) 6
BO - Bolivia 5
CZ - Repubblica Ceca 5
LY - Libia 5
AZ - Azerbaigian 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
HU - Ungheria 4
MA - Marocco 4
NI - Nicaragua 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
LB - Libano 3
NO - Norvegia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
QA - Qatar 3
BB - Barbados 2
BH - Bahrain 2
BS - Bahamas 2
ET - Etiopia 2
EU - Europa 2
GP - Guadalupe 2
LU - Lussemburgo 2
LV - Lettonia 2
MD - Moldavia 2
MN - Mongolia 2
PR - Porto Rico 2
Totale 20.304
Salva come PNG Salva come JPEG
Città #
Singapore 1.342
Southend 999
Ashburn 888
Chandler 635
Fairfield 596
San Jose 452
Ho Chi Minh City 394
Hong Kong 384
Hanoi 345
Santa Clara 325
Wilmington 268
Woodbridge 267
Houston 262
Seattle 244
Ann Arbor 228
Bologna 226
Princeton 216
Cambridge 213
Beijing 208
Dong Ket 206
Dublin 202
Hefei 183
Boardman 176
Council Bluffs 174
New York 153
Abidjan 137
Los Angeles 125
Sofia 108
Lauterbourg 105
Tokyo 103
Seoul 96
Milan 85
Lomé 73
Berlin 66
Bern 62
Nanjing 62
Amman 61
Dallas 61
Westminster 60
Da Nang 57
Redmond 55
Bremen 53
Haiphong 53
Helsinki 52
Buffalo 51
Frankfurt am Main 51
Rome 49
Shanghai 49
Padova 44
Redondo Beach 44
San Diego 44
Brussels 41
Saint Petersburg 40
São Paulo 40
Chicago 39
Turin 39
Jakarta 38
Jinan 38
Florence 37
Munich 37
Guangzhou 35
Falls Church 33
London 31
Amsterdam 30
Vienna 28
Abeokuta 27
Des Moines 27
Redwood City 27
Shenyang 27
Nuremberg 24
Changsha 23
Hải Dương 23
Toronto 23
Bengaluru 22
Lappeenranta 22
Denver 21
Hebei 21
Paris 21
Nanchang 20
Olalla 20
Phoenix 20
Verona 20
Rimini 19
San Francisco 19
Bühl 18
Montreal 18
Washington 18
Atlanta 17
Dearborn 17
Orem 17
Modena 16
Ningbo 16
Biên Hòa 15
Brooklyn 15
Quận Bình Thạnh 15
Zhengzhou 15
Baghdad 13
Hangzhou 13
Mexico City 13
Naples 13
Totale 12.573
Salva come PNG Salva come JPEG
Nome #
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 562
2018 WSES/SIS-E consensus conference: Recommendations for the management of skin and soft-tissue infections 340
How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre 322
(18)F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis. 264
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study 259
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 258
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study 256
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 253
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 247
Carbapenem resistant bacteria in Intensive Care Unit during COVID-19 pandemic: Multicenter before-after cross sectional study 242
Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: A case series 241
Impact on mortality of a bundle for the management of enterococcal bloodstream infection 233
In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment 226
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 226
Infectious diseases team for the early management of severe sepsis and septic shock in the emergency department 222
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 219
Toscana virus infections in northern Italy: laboratory and clinical evaluation. 218
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 218
An Antimicrobial Stewardship Program Based on Systematic Infectious Disease Consultation in a Rehabilitation Facility 216
Risk factors for persistent enterococcal bacteraemia: a multicentre retrospective study 214
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 214
Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure 210
Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection. 206
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study 203
Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future 202
Characterization of antibody response in neuroinvasive infection caused by Toscana virus 202
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections 202
Superficial swab versus deep-tissue biopsy for the microbiological diagnosis of local infection in advanced-stage pressure ulcers of spinal-cord-injured patients: a prospective study 201
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 200
Tolerability of pulsed high-dose L-AmB as pre-emptive therapy in patients at high risk for intra-abdominal candidiasis: A phase 2 study (LAMBDA study) 199
Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study 196
Advances in the therapy of bacterial bloodstream infections 196
Classification performance for covid patient prognosis from automatic ai segmentation—a single-center study 196
Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy 191
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation 191
Bloodstream infections in patients with liver cirrhosis 188
Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis 186
COVID-19 in solid organ transplant recipients: No difference in survival compared to general population 186
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection 183
Meningitis caused by toscana virus is associated with strong antiviral response in the CNS and altered frequency of blood antigen-presenting cells 182
Epidemiology and outcome of candidemia in internal medicine wards: A regional study in Italy 182
Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations 181
Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment 180
Clinical impact of reninangiotensin system inhibitors on in-hospital mortality of patients with hypertension hospitalized for coronavirus disease 2019 177
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 177
Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological Patient 173
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study 173
The burden of colonization and infection by carbapenemase-producing Enterobacteriaceae in the neuro-rehabilitation setting: A prospective six-year experience 172
Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. 169
Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae 169
Impact of Inflammation on Voriconazole Exposure in Critically ill Patients Affected by Probable COVID-19-Associated Pulmonary Aspergillosis 167
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 167
Clinical experience with dalbavancin for the treatment of deep sternal wound infection 167
Prognostic utility of the new definition of difficult-to-treat resistance among patients with gram-negative bloodstream infections 167
A retrospective multicentre study on dalbavancin effectiveness and cost-evaluation in sternotomic wound infection treatment: DALBA SWIT Study 166
Predictors of clinical evolution of SARS-CoV-2 infection in hematological patients: A systematic review and meta-analysis 165
Ischemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis. 164
Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections 163
Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients 163
Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation 163
Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-alpha in HIV-infected patients treated with ritonavir-boosted protease inhibitors. 161
ESCMID COVID-19 living guidelines: drug treatment and clinical management 161
Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study 160
Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in Candida spp colonized patients 160
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 158
The Gut Microbiota of Critically Ill Patients With COVID-19 158
A descriptive case series of PK/PD target attainment and microbiological outcome in critically ill patients with documented severe XDR Acinetobacter baumannii BSI and/or VAP treated with cefiderocol 157
Risk factors for candidemia in hospitalized patients with liver cirrhosis: a multicenter case-control-control study 156
Outcome Prediction for SARS-CoV-2 Patients Using Machine Learning Modeling of Clinical, Radiological, and Radiomic Features Derived from Chest CT Images 154
Predictive models for identification of hospitalized patients harboring KPC-producing klebsiella pneumoniae 153
Predictive model for bacterial co-infection in patients hospitalized for COVID-19: a multicenter observational cohort study 153
Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study 151
Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study 149
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 144
Serum bactericidal titres for monitoring antimicrobial therapy: current status and potential role in the management of multidrug-resistant Gram-negative infections 144
The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study 143
null 142
Use of critical care resources during the first 2 weeks (February 24-March 8, 2020) of the Covid-19 outbreak in Italy 142
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant Enterobacterales 140
How do I manage a patient with enterococcal bacteraemia? 138
Colonization by ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae following therapy in critically ill patients 133
Risk factors for candidemia after open heart surgery: Results from a multicenter case-control study 131
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study 130
Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018 130
Opportunistic infections in end stage liver disease 127
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 127
The role of extended infusion β-lactams in the treatment of bloodstream infections in patients with liver cirrhosis 126
Blood Hemoglobin Substantially Modulates the Impact of Gender, Morbid Obesity, and Hyperglycemia on COVID-19 Death Risk: A Multicenter Study in Italy and Spain 126
Expert clinical pharmacological advice may make an antimicrobial TDM program for emerging candidates more clinically useful in tailoring therapy of critically ill patients 125
Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT Cohort 124
Multidrug-Resistant Bacterial Infections in Solid Organ Transplant Candidates and Recipients 124
Quality of care indicators in the MAnageMent of BlOOdstream infections caused by Enterobacteriaceae (MAMBOO-E study): state of the art and research agenda 123
Prevention of infections in nursing homes: Antibiotic prophylaxis versus infection control and antimicrobial stewardship measures 121
The role of rapid and advanced microbiological methods in critical care: 2025 Emanuele Russo Delphi consensus 120
Procalcitonin-guided antibiotic therapy: An expert consensus 119
Genetic and Functional Characterization of Toll-Like Receptor Responses in Immunocompetent Patients With CMV Mononucleosis 118
Reply: Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis 115
Incidence and outcome of early Candida peritonitis after liver and pancreas transplantation 115
Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience. 114
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study 112
Totale 18.059
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.527
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.527
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.326 0 78 98 203 170 136 105 214 134 296 472 420
2022/20232.729 251 324 150 362 210 209 84 203 489 122 183 142
2023/20241.039 66 149 62 101 72 230 66 79 43 79 52 40
2024/20252.880 146 384 236 259 432 169 230 97 58 190 151 528
2025/20267.015 619 567 524 470 746 388 776 260 1.507 602 298 258
2026/2027489 243 246 0 0 0 0 0 0 0 0 0 0
Totale 20.830